ArticlePLoS pathogens2022

Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.

Judith Grau-Expósito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.